Stocks / NASDAQ / Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc.

Our Opinion

Lexeo Therapeutics Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“Behavioral tests, including Y maze, Barnes Test, and novel object recognition showed LX1001 treatment demonstrated some behavioral improvement compared to PBS-treated animals but no significant behavioral improvement compared to null-treated animals.” (Page 163) Read the full document

Company Description

Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company was incorporated in 2017 and is based in New York, New York.

Company Website: